Treating cancer using a blautia strain
AssigneeEvelo Biosciences, Inc.
InventorsBrian Goodman, Peter Sandy, Jacqueline Papkoff, Humphrey Gardner, Holly Ponichtera
Life of this patent
Estimating the term…
Abstract
Provided herein are methods and compositions related to Blautia Strain A useful as therapeutic agents.
Claims34
A method of treating cancer in a subject comprising administering to the subject a bacterial composition comprising Blautia Strain A.
(canceled)
(canceled)
12-16. (canceled)
18-21. (canceled)
24-72. (canceled)
74-75. (canceled)
(canceled)
A method of augmenting a tumor environment containing an immune cell in a subject comprising administering a bacterial composition comprising Blautia Strain A to the subject.
79-80. (canceled)
A method of augmenting a tumor environment that comprises a biomarker of patient selection in a subject comprising administering a bacterial composition comprising Blautia Strain A to the subject.
(canceled)
A method of augmenting a tumor environment comprising a biomarker associated with immune cell activity in a subject comprising administering a bacterial composition comprising Blautia Strain A to the subject.
84-89. (canceled)
A bacterial composition comprising Blautia Strain A and a pharmaceutically acceptable carrier.
92-94. (canceled)
96-100. (canceled)
102-110. (canceled)
Dependencies are inferred from the claim text.